- 全部删除
- 您的购物车当前为空
S100A8 & S100A9 Heterodimer Protein, Human, Recombinant (His) is expressed in E. coli. The accession number is P05109 (S100A8) & P06702 (S100A9).
规格 | 价格 | 库存 | 数量 |
---|---|---|---|
100 μg | ¥ 5,390 | 5日内发货 | |
500 μg | ¥ 21,600 | 5日内发货 |
生物活性 | Activity has not been tested. It is theoretically active, but we cannot guarantee it. |
产品描述 | S100A8 & S100A9 Heterodimer Protein, Human, Recombinant (His) is expressed in E. coli. The accession number is P05109 (S100A8) & P06702 (S100A9). |
种属 | Human |
表达系统 | E. coli |
标签 | C-His |
蛋白编号 | P05109 (S100A8) & P06702 (S100A9) |
别名 | S100 calcium-binding protein A9,S100 calcium-binding protein A8,Protein S100-A9,Protein S100-A8,MRP-8,MRP-14,CFAG,Calgranulin-A |
蛋白构建 | S100A8 |
蛋白纯度 | > 95% as determined by BisTris PAGE |
分子量 | 11.7 kDa (S100A8)&13.2 kDa (S100A9) (Predicted same as reducing conditions) |
内毒素 | < 1.0 EU per μg protein as determined by the LAL method. |
缓冲液 | Lyophilized from 0.22μm filtered solution in 2mM DTT, PBS (pH 7.2). |
复溶方法 | Reconstitute the lyophilized protein in sterile deionized water. The product concentration should not be less than 100 μg/ml. Before opening, centrifuge the tube to collect powder at the bottom. After adding the reconstitution buffer, avoid vortexing or pipetting for mixing. |
存储 | Upon receiving, the product remains stable up to 6 months at -20 °C or below. Upon reconstitution, the product should be stable for 3 months at -80 °C. Avoid repeated freeze-thaw cycles. |
运输方式 | In general, Lyophilized powders are shipping with blue ice. Solutions are shipping with dry ice. |
研究背景 | Calprotectin, a member of the widespread calcium-binding S-100 protein family, is present in remarkably high concentration in the cytoplasm of human neutrophils. The calprotectin molecule is composed of light (MRP8) and heavy (MRP14) subunits. Although not secreted from intact neutrophils, calprotectin release from dead and dying neutrophils creates high concentrations of the protein in inflammatory or abscess fluids and in the intestinal tract lumen of patients with inflammatory bowel disease. |